최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Diabetes care, v.27 no.9, 2004년, pp.2149 - 2153
Lau, Denys T. (Pfizer Research Fellowship Program, Department of Health Management and Policy, The University of Michigan School of Public Health, Ann Arbor, Michigan) , Nau, David P. (Department of Social and Administrative Sciences, The University of Michigan College of Pharmacy, Ann Arbor, Michigan)
OBJECTIVE-This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.RESEARCH DESIGN AND METHODS-Using administrative claims data (2000-2001) from a managed care organization in the Midwestern U.S.,...
10.2337/diacare.25.6.1015 Schectman JM, Nadkarni MM, Voss JD: The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25:1015-1021, 2002
10.1056/NEJM199309303291401 Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
10.1016/S0140-6736(98)07019-6 UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
10.1016/S0149-2918(01)80110-7 Dailey G, Kim MS, Lian JF: Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus. Clin Ther 23:1311-1320, 2001
10.1046/j.1464-5491.2002.00689.x Donnan PT, MacDonald TM, Morris AD: Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 19:279-284, 2002
10.1016/S1262-3636(07)70011-3 Guillausseau PJ: Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes: a survey in general practice. Diabetes Metab 29:79-81, 2003
Nau DP, Garber MC, Herman WH: The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs. Am J Manag Care 10:118-123, 2004
10.1176/ajp.152.6.856 Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA: Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatr 152:856-861, 1995
10.1097/00005650-200208000-00002 Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 40:630-639, 2002
10.1176/appi.ps.52.6.805 Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 52:805-811, 2001
10.1093/ajhp/52.14_Suppl_3.S27 Cramer JA: Relationship between medication adherence and medical outcomes. Am J Health Syst Pharm 52:527-529, 1995
10.1007/BF01858007 Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S: The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 17:347-360, 1994
10.1016/S0149-2918(03)80347-8 Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT: Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 25:2958-2971, 2003
10.1097/00005650-199909000-00002 Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to anti-hypertensive therapy. Med Care 37:846-857, 1999
10.1016/S0149-2918(99)80026-5 Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074-1090, 1999
10.1520/JFS14375J Duncan JC, Rogers R: Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci 43:1133-1137, 1998
10.2337/diacare.23.1.23 Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL: Depressive symptoms and metabolic control in African Americans with type 2 diabetes. Diabetes Care 23:23-29, 2000
10.1111/j.1365-2710.1993.tb00591.x Skaer TL, Sclar DA, Markowski DJ, Won JK: Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 18:295-299, 1993
10.1016/0021-9681(87)90171-8 Charlson ME, Pompei P, Ales KL, McKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-383, 1987
10.1016/0895-4356(93)90103-8 Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 46:1075-1079, 1993
10.1016/0895-4356(93)90106-B Romano PS, Roos LL, Jollis JG: Furthering evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol 46:1085-1090, 1993
Diggle PJ, Liang KY, Zeger S: Transition models. In Analysis of Longitudinal Data. New York, Oxford University Press, 1999, p. 45-62
Chousa FP, Guillen VFG, Otero MD, Beltran DO, Lopez RP, Sanchez JM: Usefulness of six indirect methods to evaluate drug therapy compliance in non-insulin-dependent diabetes mellitus. Revista Clinica Espanola 197:555-559, 1997
10.1111/j.1445-5994.1984.tb04276.x Peterson GM, McLean S, Senator GB: Determinants of patient compliance, control, presence of complications, and handicap in non-insulin-dependent diabetes. Aust N Z J Med 14:135-141, 1984
10.1001/jama.285.2.182 Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA 285:182-189, 2001
10.1097/00005650-198808000-00007 Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records: description and validation. Med Care 26:814-823, 1988
Rudd P. The measurement of compliance: medication taking. In Developmental Aspects of Health Compliance Behavior. Krasnegor NA, Epstein L, Johnson SF, Yaffe SJ, Eds. Hillsdale, NJ, Lawrence Erlbaum Associates, 1993, p. 185-213
10.1056/NEJM199807233390404 Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
10.1136/bmj.321.7258.405 Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): progressive observational study. BMJ 321:405-412, 2000
10.1001/archinte.157.2.181 Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS: Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 157:181-188, 1997
10.2337/diacare.24.1.51 Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R: Potential short-term economic benefits of improved glycemic control. Diabetes Care 24:51-55, 2001
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.